Immunotherapy Advances
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.4 | Q2 | 66.1% | 1.504 | Q1 | 92.0% |
| 2024 | 4.9 | Q1 | 76.1% | 1.565 | Q1 | 92.8% |
| 2023 | 4.1 | Q2 | 57.1% | — | 1.5% | |
| 2022 | — | — | — | 3.7% | ||
| 2021 | — | — | — | 5.2% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2732-4303
region
Western Europe
coverage
2021-2026